Pages

Wednesday, October 23, 2013

MolMed expands in the United States the Phase III trial of TK for the ...

The study, already ongoing in Europe, foresees patient enrolment in 16 clinical centres worldwide.

http://www.pr-inside.com/molmed-expands-in-the-united-states-r3836214.htm

No comments:

Post a Comment